Reneo Pharmaceuticals



Reneo is a clinical stage pharmaceutical company focused on the development of therapies for patients with genetic mitochondrial diseases. Many of these diseases are associated with deficits in cellular metabolism and energy production. Our goal is to improve daily function and quality of life of patients suffering from these diseases, most specifically, by improving how their mitochondria work, preserving muscle ...

Gregory J. Flesher
President & Chief Executive Officer
Gregory J. Flesher
Wendy Johnson
Chief Operating Officer
Alejandro Dorenbaum
Chief Medical Officer
Lynn Purkins
VP of Clinical Operations

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.